Three-year Follow-Up of Outcomes with KTE-X19 in Patients with Relapsed/refractory Mantle Cell Lymphoma in ZUMA-2.
JOURNAL OF CLINICAL ONCOLOGY(2022)
关键词
Mantle Cell Lymphoma
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2022)